The effects of V2 antagonist (OPC-31260) on endolymphatic hydrops
The effects of V2 antagonist (OPC-31260) on endolymphatic hydrops
复制标题
DOI:
10.1016/s0378-5955(03)00135-7
复制
发表时间:
2003-08-01
期刊:
影响因子:
2.8
通讯作者:
Takeuchi, S
中科院分区:
文献类型:
--
作者:
Takeda, T;Sawada, S;Takeuchi, S
In the present study, two experiments were performed to investigate the influence of OPC-31260 on experimentally induced endolymphatic hydrops in guinea pigs and the regulation of aquaporin-2 (AQP2) mRNA expression in the rat inner ear. In morphological studies, the increases in the ratios of the length of Reissner's membrane (IR-L) and the cross-sectional area of the scala media (IR-S) were quantitatively assessed among normal guinea pigs (normal ears) and three groups with hydropic ears: hydropic ears with no infusion (non-infusion hydropic ears), hydropic ears with an infusion of physiological saline into the scala tympani (saline-infused hydropic cars) and hydropic ears with infusion of 0.3% OPC-31260 into the scala tympani (OPC-infused hydropic ears). IR-Ls in the experimental groups were markedly larger than in the normal ear group, but there was no significant difference among the groups of non-infusion hydropic cars, saline-infused hydropic ears and OPC-infused hydropic ears. The IR-Ss of non-infusion hydropic ears and saline-infused hydropic ears (48.8-49.3%) were statistically different from that of normal ears (6.5%) (Dunnet multiple comparison test, P < 0.01). However, IR-S of the OPC-infused hydropic ears (- 14.8%) was significantly smaller than those of non-infusion hydropic ears and saline-infused hydropic ears (one-way ANOVA, P < 0.0 1). In the quantitative polymerase chain reaction study, a comparison of the ratio of AQP2 and beta-actin mRNA (M-AQP2/Mbeta-actin) was made between water-injected and OPC-31260-injected rats. An intravenous injection of OPC-31260 resulted in a significant decrease in M-AQP2/ Mbeta-actin both in the cochlea and in the endolymphatic sac (t-test, P < 0.001). These results indicate that water homeostasis in the inner ear is regulated via the vasopressin-AQP2 system, and that the vasopressin type-2 antagonist OPC-31260 is a promising drug in the treatment of Meniere's disease. (C) 2003 Elsevier B.V. All rights reserved.